Analysis of long-term survivors after surgical resection for invasive pancreatic cancer

HPB

Volumn 7, Issue 2, 2005, Pages 129-134

  Kure, Shigehiro ^a   Kaneko, Tetsuya ^a   Takeda, Shin ^a   Inoue, Soichiro ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinicopathological factors; Long term survival; Pancreatic cancer

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PORTAL VEIN; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TUMOR VOLUME;

EID: 20044395967     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820510003744     Document Type: Article

References (37)

1. Kaneko T, Kimata H, Sugimoto H, Inoue S, Ito S, Ishiguchi T, et al. Power doppler ultrasonography for the assessment of vascular invasion by pancreatic cancer. Pancreatology 2002;2:61-8.
2. Tezel E, Kaneko T, Sugimoto H, Takeda S, Inoue S, Nagasaka T, et al. Clinical significance of intraportal endovascular ultrasonography for the diagnosis of extrapancreatic nerve plexus invasion by pancreatic carcinoma. Pancreatology 2004;4:76-81.
3. Kaneko T, Nakao A, Inoue S, Harada A, Nonami T, Itoh S, et al. Intraportal endovascular ultrasonography in the diagnosis of portal vein invasion by pancreatobiliary carcinoma. Ann Surg 1995;222:711-18.
4. Lygidakis NJ, Papadopoulou P. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer? Hepatogastroenterology 1995;42:587-96.
5. Nakao A, Nonami T, Harada A, Kasuga T, Takagi H. Portal vein resection with a new antithrombogenic catheter. Surgery 1990;108:913-18.
6. Nakao A, Takagi H. Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology 1993;40:426-9.
7. Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery 1995;117:50-5.
8. Ozaki H, Takehisa H, Mizumoto R, Matsuno S, Matsumoto Y, Nakayama T, et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 1999;29:16-22.
9. Nakao A, Harada A, Nonami T, Kaneko T, Murakami H, Inoue S, et al. Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg 1995;82:399-402.
10. Nakao A, Harada A, Nonami T, Kaneko T, Nomoto S, Koyama H, et al. Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg 1997;84:1090-2.
11. Nakao A, Harada A, Nonami T, Kaneko T, Takagi H. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 1996;12:357-61.
12. Bakkevold KE, Kambestrad B. Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater - the prognostic factors influencing the long-term results. Eur J Surg Oncol 1993;19:147-61.
13. Fortner JG, Klimstra DS, Senie RT, Maclean BJ. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg 1996;223:147-53.
14. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Ann Surg 1996;3:273-9.
15. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. Ann Surg 1995;221:721-33.
16. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the west midlands: an epidemiological study. Br J Surg 1995;82: 111-15.
17. Kedra B, Popiela T, Sierzega M, Precht A. Prognostic factors of long-term survival after resective procedures for pancreatic cancer. Hepatogastroenterology 2001;48:1762-6.
18. Ahmad NA, Lewis JD, Ginsberg GG, Haller DG, Morris JB, Williams NN, et al. Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol 2001;96:2609-15.
19. Neoptolemos JP, Russell RCG, Bramhall S, Theis JB. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. Br J Surg 1997;84:1370-6.
20. Mannell A, Van Heerden JA, Weiland LH, Ilstrup DM. Factors influencing survival after resection for ductal adenocarcinoma of the pancreas. Ann Surg 1986;203:403-7.
21. Lerut JP, Gianello PR, Otte JB, Kestens PJ. Pancreaticoduodenal resection. Ann Surg 1984;199:432-7.
22. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221: 59-66.
23. Tsuchiya R, Oribe T, Noda T. Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas. Am J Gastroenterol 1985;80:459-62.
24. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120-5.
25. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68-73.
26. Yoshizawa K, Nagai H, Kurihara K, Sata N, Kawai T, Saito K. Long-term survival after surgical resection for pancreatic cancer. Hepatogastroenterology 2001;48:1153-6.
27. Nagakawa T, Ohta T, Kayahara M, Mori K, Ueda S, Kobayashi K, et al. Clinicopathological evaluation of long-term survivors treated for cancer of the head of pancreas. Hepatogastroenterology 1998;45:1865-9.
28. Nakao A, Kaneko T, Takeda S, Inoue S, Harada A, Nomoto S, et al. The role of extended radical operation for pancreatic cancer. Hepatogastroenterology 2001;48:949-52.
29. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Ann Surg 1993;217:144-8.
30. Japan Pancreas Society. Classification of pancreatic carcinoma, 2nd English edn. Tokyo: Kanehara & Co. Ltd. 2003.
31. Johnstone PAS, Sindelar WF. Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial. Pancreas 1993;8:535-9.
32. Kaneko T, Nakao A, Inoue S, Nomoto S, Nagasaka T, Nakashima N, et al. Extrapancreatic nerve plexus invasion by carcinoma of the head of the pancreas. Diagnosis with intraportal endovascular ultrasonography. Int J Pancreatol 1996;19:1-7.
33. International Union Against Cancer (UICC), Sobin LH, Wittekind CH. TNM Classification of malignant tumours, 6th edn. Chichester: Wiley, 2002.
34. Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H. Intraoperative radiotherapy for resectable and unresectable pancreatic carcinoma. J Hep Bil Pancr Surg 1994;1:252-6.
35. Takeda S, Inoue S, Kaneko T, Harada A, Nakao A. The role of adjuvant therapy for pancreatic cancer. Hepatogastroenterology 2001;48:953-6.
36. Nakao A, Harada A, Nonami T, Kaneko T, Takeda S, Kurokama T, et al. Intraoperative radiotherapy for pancreatic carcinoma with hepatic or peritoneal metastases. Hepatogastroenterology 1997;44:1469-71.
37. Dobelbower RR, Bronn DG. Radiotherapy in the treatment of pancreatic cancer. Baillieres Clin Gastroenterol 1990;4: 969-83.